Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Comment

被引：1
|
作者：
Guven, D. C. [1 ]
Taban, H. [1 ]
Dizdar, O. [1 ]
机构：
[1] Hacettepe Univ, Canc Inst, Dept Med Oncol, Ankara, Turkey
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2022年 / 28卷 / 01期
关键词：
adjuvant; capecitabine; triple negative breast cancer; PHASE-III TRIAL; COMBINATION; DOCETAXEL;
D O I：
10.1177/10781552211045909
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [31] Irinotecan and capecitabine combination chemotherapy in a patient with triple-negative breast cancer relapsed after adjuvant chemotherapy with anthracycline and taxane
    Lee, Anna
    Go, Se-Il
    Lee, Won Sup
    Lee, Un Seok
    Kim, Moon Jin
    Kang, Myoung Hee
    Lee, Gyeong-Won
    Kim, Hoon-Gu
    Kang, Jung Hun
    Jeon, Kyung-Nyeo
    Cho, Jae Min
    Lee, Jeong-Hee
    TUMORI, 2015, 101 (01) : E9 - E12
  • [32] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [33] Clinical effectiveness and safety of gemcitabine plus capecitabine in the treatment of advanced triple-negative breast cancer
    Wang, Ya
    Zhu, Yulan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (05): : 1945 - 1952
  • [34] Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer
    Stover, Daniel G.
    Winer, Eric P.
    BREAST, 2015, 24 : S132 - S135
  • [35] Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
    Tian, Hao
    Ma, Dandan
    Tan, Xuanni
    Yan, Wenting
    Wu, Xiujuan
    He, Cheng
    Zhong, Ling
    Zhang, Yan
    Yu, Bingjie
    Zhang, Yi
    Qi, Xiaowei
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] Adjuvant chemotherapy in small node-negative triple-negative breast cancer
    Steenbruggen, Tessa G.
    van Werkhoven, Erik
    van Ramshorst, Mette S.
    van Ramshorst, Mette S.
    Dezentje, Vincent O.
    Kok, Marleen
    Linn, Sabine C.
    Siesling, Sabine
    Sonke, Gabe S.
    EUROPEAN JOURNAL OF CANCER, 2020, 135 : 66 - 74
  • [37] Postneoadjuvant treatment for triple-negative breast cancer
    Trapani, Dario
    Ferraro, Emanuela
    Giugliano, Federica
    Bielo, Luca Boscolo
    Curigliano, Giuseppe
    Burstein, Harold J.
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (06) : 623 - 634
  • [38] The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Xingfa Huo
    Jinming Li
    Fuxing Zhao
    Dengfeng Ren
    Raees Ahmad
    Xinyue Yuan
    Feng Du
    Jiuda Zhao
    BMC Cancer, 21
  • [39] Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature
    Liu, Li
    Brown, Erika N.
    Abu-Shahin, Fadi, I
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 703 - 709
  • [40] Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131
    Smith, Karen L.
    Zhao, Fengmin
    Mayer, Ingrid A.
    Tevaarwerk, Amye J.
    Garcia, Sofia F.
    Arteaga, Carlos L.
    Symmans, William F.
    Park, Ben H.
    Burnette, Brian L.
    Makower, Della F.
    Block, Margaret
    Morley, Kimberly A.
    Jani, Chirag R.
    Mescher, Craig
    Dewani, Shabana J.
    Brown-Glaberman, Ursa
    Flaum, Lisa E.
    Mayer, Erica L.
    Sikov, William M.
    Rodler, Eve T.
    Demichele, Angela M.
    Sparano, Joseph A.
    Wolff, Antonio C.
    Miller, Kathy D.
    Wagner, Lynne I.
    CANCER, 2024, 130 (10) : 1747 - 1757
12345